In March 2015 la Fédération française d'athlétisme (FFA) – the French Athletics Federation – has reported an anti-doping rule violation against the Respondent M56 after her sample tested positive for the prohibited substances prednisone and prednisolone.
Because the Respondent was no member of the FFA the AFLD obtained automatically jurisdiction to open disciplinary proceedings against the Respondent. After notification of the violation the Respondent filed a statement with medical evidence in her defence.
The Respondent stated that she non intentionally used prescribed medication as treatment for the rheumatoid arthritis she suffered and she mentioned her medication on the Doping Control Form.
The AFLD accepts the Respondent’s statement and medical evidence and concludes that the use of the medication with the prohibited substances were justified.
Therefore the AFLD decides on 22 October 2015 to to discharge the Respondent M56 from further prosecution.
